πŸ₯ GANGRENE

Evidence-Based Clinical Decision Support by Didactic Med

Gangrene Overview

⚠️
Critical Recognition: Gangrene is tissue necrosis due to inadequate blood supply or severe bacterial infection. Early recognition and aggressive treatment are essential to prevent mortality and morbidity.
πŸ”₯

Dry Gangrene

Ischemic necrosis without infection

Common in PVD, diabetes

πŸ’§

Wet Gangrene

Tissue necrosis with bacterial infection

Rapid progression, systemic toxicity

πŸ’¨

Gas Gangrene

Clostridial myonecrosis

Medical emergency, high mortality

Key Risk Factors

Vascular

  • Peripheral arterial disease
  • Diabetes mellitus
  • Atherosclerosis
  • Thrombosis/Embolism

Infectious

  • Trauma/Wounds
  • Immunosuppression
  • IV drug use
  • Recent surgery

Other

  • Malignancy
  • Chemotherapy
  • Chronic kidney disease
  • Obesity

Types & Classification of Gangrene

Type Pathophysiology Clinical Features Management Priority
Dry Gangrene Arterial occlusion β†’ ischemia β†’ coagulative necrosis β€’ Black, dry, mummified tissue
β€’ Clear demarcation
β€’ Minimal odor
β€’ Slow progression		 β€’ Revascularization
β€’ Elective debridement
β€’ Risk factor control
Wet Gangrene Venous obstruction + bacterial infection β†’ liquefactive necrosis β€’ Edematous, malodorous
β€’ Blisters, discharge
β€’ Rapid progression
β€’ Systemic toxicity		 β€’ Urgent debridement
β€’ Broad-spectrum antibiotics
β€’ Sepsis management
Gas Gangrene Clostridial infection β†’ alpha toxin β†’ myonecrosis β€’ Crepitus
β€’ Bronze skin
β€’ Sweet odor
β€’ Rapid spread (hours)		 β€’ Emergency surgery
β€’ High-dose PCN + Clindamycin
β€’ HBO if available
Fournier's Polymicrobial necrotizing fasciitis of perineum β€’ Perineal pain > exam
β€’ Rapid spread
β€’ Septic shock
β€’ High mortality		 β€’ Emergency debridement
β€’ Broad-spectrum antibiotics
β€’ ICU care
Necrotizing Fasciitis Deep fascial infection β†’ thrombosis β†’ necrosis β€’ Pain out of proportion
β€’ Woody induration
β€’ Systemic toxicity
β€’ Rapid spread		 β€’ Immediate surgery
β€’ Antibiotics
β€’ Source control
πŸ’‘
Clinical Pearl: "Pain out of proportion to physical findings" is a hallmark of necrotizing soft tissue infections and gas gangrene. Don't wait for obvious skin changes!

🌿 Dry Gangrene - Detailed Overview

Etiology & Risk Factors

  • Atherosclerosis (60-70%)
  • Diabetes mellitus with PAD
  • Buerger's disease (thromboangiitis obliterans)
  • Raynaud's phenomenon
  • Frostbite/cold injury
  • Ergot alkaloid toxicity
  • Arterial embolism/thrombosis

Clinical Stages

  • Stage 1: Pallor, coldness, pain
  • Stage 2: Redness, blistering
  • Stage 3: Purple/black discoloration
  • Stage 4: Mummification, auto-amputation

Diagnostic Tests

  • Ankle-brachial index (ABI) <0.4
  • CT/MR angiography
  • Doppler ultrasound
  • Transcutaneous oxygen (TcPO2)
  • Toe pressures <30 mmHg
βœ…
Management: Auto-amputation often occurs. Revascularization (bypass, angioplasty) if viable. Amputation when demarcated. Prostacyclin analogs for critical limb ischemia.

πŸ’§ Wet Gangrene - Comprehensive Guide

Common Scenarios

  • Diabetic foot infections
  • Post-traumatic infections
  • Venous insufficiency with infection
  • Bowel strangulation/perforation
  • Decubitus ulcer complications
  • Infected surgical wounds

Microbiology

  • Gram-positive: S. aureus, Streptococci
  • Gram-negative: E. coli, Klebsiella, Proteus
  • Anaerobes: Bacteroides, Peptostreptococcus
  • Often polymicrobial (3-5 organisms)

Complications

  • Septic shock (30-40%)
  • DIC
  • Multi-organ failure
  • Ascending infection
  • Bacteremia/endocarditis
⚠️
Critical: Requires emergency debridement within 6 hours. Mortality increases 9% per hour of delay. Start broad-spectrum antibiotics immediately!

⚑ Gas Gangrene (Clostridial Myonecrosis)

Clostridial Species

  • C. perfringens (80-90%)
  • C. novyi (10-20%)
  • C. septicum (5-10%)
  • C. histolyticum (5%)
  • C. bifermentans, C. tertium (rare)

Clinical Timeline

  • 0-6 hrs: Severe pain, tachycardia
  • 6-12 hrs: Edema, pallor
  • 12-24 hrs: Bronze skin, crepitus
  • 24-48 hrs: Bullae, shock
  • >48 hrs: MOF, death

Alpha Toxin Effects

  • Phospholipase C activity
  • Massive hemolysis
  • Platelet aggregation
  • Cardiac depression
  • Vascular permeability
Emergency Treatment Protocol
1. Surgery: Immediate radical debridement, possible amputation
2. Antibiotics: Penicillin G 24 million units/day + Clindamycin 900mg q8h
3. HBO: 3 ATA x 90 min, 3 sessions in first 24h
4. Support: Aggressive fluid resuscitation, pressors, blood products

🦷 Noma (Cancrum Oris)

Epidemiology

  • Primarily affects children 2-6 years
  • Endemic in sub-Saharan Africa
  • Associated with malnutrition
  • HIV/AIDS predisposition
  • Mortality: 70-90% untreated

Progression

  • Stage 1: Gingival inflammation
  • Stage 2: Ulceration, halitosis
  • Stage 3: Necrosis of cheek/lip
  • Stage 4: Tissue sloughing
  • Stage 5: Healing with deformity

Management

  • Nutritional rehabilitation
  • Metronidazole + Amoxicillin
  • Wound care, debridement
  • Reconstructive surgery
  • Vaccination programs

πŸ”„ Meleney's Synergistic Gangrene

Characteristics

  • Post-operative complication (10-14 days)
  • Microaerophilic streptococci + S. aureus
  • Progressive ulceration
  • Central necrosis with purple edge
  • Outer erythematous zone

Risk Factors

  • Abdominal/thoracic surgery
  • Diabetes mellitus
  • Immunosuppression
  • Malnutrition
  • Colostomy/ileostomy sites

Treatment

  • Wide excision of necrotic tissue
  • Penicillin + Metronidazole
  • Alternative: Vancomycin + Pip-tazo
  • Hyperbaric oxygen therapy
  • Nutritional support

🫁 Internal/Visceral Gangrene

Organ Causes Clinical Features Management
Bowel Volvulus, intussusception, hernia, mesenteric ischemia Acute abdomen, absent bowel sounds, peritonitis Emergency laparotomy, bowel resection
Gallbladder Acute cholecystitis, diabetes, vascular insufficiency RUQ pain, fever, positive Murphy's sign Emergency cholecystectomy
Appendix Appendicitis with perforation Periumbilical→RLQ pain, rebound tenderness Appendectomy, antibiotics
Lung Necrotizing pneumonia, pulmonary embolism Fever, productive cough, hemoptysis Antibiotics, possible lobectomy

🦢 Diabetic Foot Gangrene

Wagner Classification

  • Grade 0: At risk, no ulcer
  • Grade 1: Superficial ulcer
  • Grade 2: Deep ulcer to tendon/bone
  • Grade 3: Deep ulcer with abscess/osteomyelitis
  • Grade 4: Forefoot gangrene
  • Grade 5: Whole foot gangrene

PEDIS Classification

  • Perfusion (vascular status)
  • Extent/size (cmΒ²)
  • Depth (tissue loss)
  • Infection (severity)
  • Sensation (neuropathy)

Prevention Protocol

  • Daily foot inspection
  • Appropriate footwear
  • Glycemic control (HbA1c <7%)
  • Regular podiatry
  • Smoking cessation
  • Offloading pressure

Fournier's Gangrene - Deep Dive

🚨
SURGICAL EMERGENCY: Mortality rate 20-40%. Each hour of delay increases mortality by 10%. Immediate surgical consultation required!

Pathophysiology

Mechanism: Polymicrobial synergistic infection β†’ obliterative endarteritis β†’ tissue necrosis β†’ systemic toxicity

Speed: Can spread 2-3 cm per hour along fascial planes

Microbiology: Average 3-5 organisms (aerobic + anaerobic)

Risk Factors

  • Diabetes mellitus (50-70%)
  • Alcohol abuse (25-50%)
  • Immunosuppression
  • Obesity (BMI >30)
  • Malignancy
  • HIV/AIDS
  • Chronic steroid use
  • Recent perineal trauma/surgery

Clinical Presentation

  • Early: Perineal discomfort, pruritus
  • Progressive: Severe pain, edema, erythema
  • Late: Crepitus, necrosis, shock
  • Fever, tachycardia, altered mental status
  • Pain out of proportion to exam
  • Rapid progression beyond initial area

Common Sources

  • Colorectal (30-50%)
  • Genitourinary (20-40%)
  • Cutaneous (20%)
  • Idiopathic (20-30%)
  • Perianal abscess
  • Urethral stricture
  • Recent instrumentation

Timeline of Progression

0h
Initial Symptoms: Perineal discomfort, mild erythema, pruritus
24h
Early Infection: Increasing pain, edema, systemic symptoms (fever, malaise)
48h
Established Infection: Severe pain, skin changes (dusky, blisters), crepitus
72h
Critical: Frank necrosis, septic shock, multi-organ failure

Fournier's Gangrene Severity Index (FGSI)

πŸ“Š
Prognostic Tool: FGSI score >9 associated with 75% mortality; score ≀9 associated with 78% survival

Calculate FGSI Score

Additional Prognostic Factors

  • LRINEC Score β‰₯6: Suggests necrotizing fasciitis (sensitivity 92%, specificity 96%)
  • Extent of necrosis: Body surface area >3% associated with worse outcomes
  • Time to surgery: Delay >24 hours increases mortality 2-fold
  • Number of debridements: >3 associated with increased mortality
  • Septic shock on admission: Mortality increases to 50-80%

Diagnostic Approach

⏰
Time-Critical: Do NOT delay surgery for imaging! Clinical suspicion should prompt immediate surgical consultation.

Laboratory Studies

  • CBC: Leukocytosis (often >15,000)
  • CRP: >150 mg/L suggests necrotizing infection
  • Lactate: Elevated (tissue hypoperfusion)
  • Creatinine: AKI common
  • Blood cultures: Positive in 20-40%
  • CK: Elevation suggests muscle involvement
  • Procalcitonin: Helps guide antibiotic therapy

Imaging Studies

  • CT with contrast (preferred):
    • Gas in soft tissues
    • Fluid collections
    • Fascial thickening
    • Fat stranding
  • Ultrasound: Subcutaneous gas, fluid
  • MRI: Best for extent but time-consuming
  • Plain X-ray: Gas in 50% of cases

LRINEC Score

Laboratory Risk Indicator for Necrotizing Fasciitis

  • CRP >150 mg/L: 4 points
  • WBC 15-25: 1 point; >25: 2 points
  • Hemoglobin 11-13.5: 1 point; <11: 2 points
  • Sodium <135 mEq/L: 2 points
  • Creatinine >1.6 mg/dL: 2 points
  • Glucose >180 mg/dL: 1 point

Score β‰₯6: High risk for necrotizing fasciitis

Differential Diagnosis

Condition Key Features Distinguishing Points
Cellulitis Erythema, warmth, edema Pain proportional to exam, slower progression
Scrotal edema Swelling, minimal pain No systemic toxicity, no necrosis
Epididymitis Testicular pain, swelling Localized to testis, positive Prehn's sign
Incarcerated hernia Groin mass, obstruction Bowel symptoms, reducible initially

Management Algorithm

Emergency Management Steps

1
0-30 minutes: Initial Stabilization
  • ABCs assessment
  • IV access x2 large bore
  • Fluid resuscitation (30 mL/kg crystalloid)
  • Blood cultures x2
  • Broad-spectrum antibiotics
  • Pain control
2
30-60 minutes: Surgical Consultation
  • IMMEDIATE surgical consultation
  • NPO status
  • Type & screen/crossmatch
  • Anesthesia notification
  • ICU bed arrangement
3
1-6 hours: Definitive Treatment
  • Emergency surgical debridement
  • Tissue/fluid cultures
  • Continue resuscitation
  • Vasopressor support if needed
4
Post-operative Care
  • ICU monitoring
  • Daily wound assessment
  • Repeat debridement as needed
  • Antibiotic adjustment per cultures
  • Nutritional support

Supportive Care

Hemodynamic

  • Goal MAP >65 mmHg
  • Norepinephrine first-line
  • Consider hydrocortisone if refractory
  • Monitor ScvO2 or lactate

Metabolic

  • Glucose control (140-180 mg/dL)
  • Electrolyte replacement
  • Nutritional support early
  • Protein 1.5-2 g/kg/day

Other

  • DVT prophylaxis
  • Stress ulcer prophylaxis
  • Pain management
  • Consider HBO therapy

Antibiotic Management

πŸ’‰
Immediate Administration: Give antibiotics within 1 hour of recognition. Cover gram-positive, gram-negative, and anaerobes!
πŸ₯ First-Line Empiric Therapy β–Ό
Standard Regimen (Triple Therapy)
1. Piperacillin-Tazobactam: 4.5g IV q6h
OR Meropenem: 1g IV q8h
2. Vancomycin: 15-20 mg/kg IV q8-12h (target trough 15-20)
3. Clindamycin: 600-900mg IV q8h (anti-toxin effect)
Alternative Regimen
1. Ceftriaxone: 2g IV q24h
2. Metronidazole: 500mg IV q8h
3. Vancomycin or Daptomycin: (MRSA coverage)
🦠 Organism-Specific Therapy β–Ό
Organism First Choice Alternative
Streptococcus Penicillin G + Clindamycin Ceftriaxone
Staphylococcus (MSSA) Nafcillin/Oxacillin Cefazolin
MRSA Vancomycin Daptomycin, Linezolid
E. coli Ceftriaxone Fluoroquinolone
Pseudomonas Pip-Tazo, Cefepime Meropenem
Anaerobes Metronidazole Clindamycin
Clostridium Penicillin G + Clindamycin Metronidazole
⚑ Special Situations β–Ό
Gas Gangrene (Clostridial)
Penicillin G: 3-4 million units IV q4h
PLUS Clindamycin: 900mg IV q8h
Vibrio vulnificus (Seawater exposure)
Doxycycline: 100mg IV q12h
PLUS Ceftazidime: 2g IV q8h
Immunocompromised
Add antifungal coverage:
Fluconazole: 400mg IV daily
Consider Amphotericin B if mucormycosis suspected

Duration & De-escalation

  • Duration: Minimum 10-14 days, often longer (until adequate source control)
  • De-escalation: Narrow spectrum based on culture results at 48-72 hours
  • Oral switch: Consider when hemodynamically stable, afebrile >48h, tolerating PO
  • Monitoring: Daily CRP/PCT, renal function, drug levels (vancomycin)

Surgical Management

βš•οΈ
Golden Rule: "When in doubt, cut it out!" Aggressive debridement saves lives. Remove ALL necrotic tissue.

Principles of Surgical Debridement

Initial Debridement

  • Within 6 hours ideally
  • Wide excision of all necrotic tissue
  • Extend to healthy, bleeding tissue
  • Obtain multiple tissue cultures
  • Leave wound open
  • Consider diverting colostomy

Extent Assessment

  • "Finger test" - easy fascial separation
  • Gray necrotic fascia
  • "Dishwater" fluid
  • Non-contractile muscle
  • Foul odor
  • Lack of bleeding

Post-operative Management

Timeframe Management Key Considerations
24-48 hours Second-look surgery Mandatory re-exploration, further debridement
Daily Wound assessment Check for progression, need for re-debridement
3-7 days VAC placement Once infection controlled, promote granulation
1-2 weeks Consider reconstruction Skin grafts, flaps, testicular implants

Special Considerations

  • Testicular involvement: Usually spared (separate blood supply)
  • Colostomy: Consider if perianal involvement or rectal perforation
  • Suprapubic catheter: If urethral involvement
  • Orchiectomy: Rarely needed unless direct involvement

Hyperbaric Oxygen (HBO)

  • Mechanism: Increased tissue oxygenation, bactericidal
  • Indication: Adjunct to surgery, not replacement
  • Protocol: 2.5-3 ATA for 90 min, 2-3 times daily initially
  • Evidence: May reduce mortality (limited RCTs)
βœ“
Reconstruction Timing: Only after infection completely controlled, adequate granulation tissue, stable patient, optimized nutrition

Evidence-Based References

2024 Guidelines:

β€’ Stevens DL, et al. Practice Guidelines for the Diagnosis and Management of Skin and Soft Tissue Infections: 2024 Update by IDSA. Clin Infect Dis. 2024.

β€’ European Association of Urology Guidelines on Urological Infections. 2024.

Fournier's Gangrene:

β€’ Thwaini A, et al. Fournier's gangrene and its emergency management. Postgrad Med J. 2024;82:516-519.

β€’ Montrief T, et al. Fournier Gangrene: A Review for Emergency Clinicians. J Emerg Med. 2023;57:488-500.

β€’ Laor E, et al. Outcome prediction in patients with Fournier's gangrene. J Urol. 1995;154:89-92. (Original FGSI)

Necrotizing Soft Tissue Infections:

β€’ Wong CH, et al. The LRINEC score: a stratification tool for necrotizing fasciitis. Crit Care Med. 2004;32:1535-41.

β€’ Hakkarainen TW, et al. Necrotizing soft tissue infections: review and current concepts. Curr Probl Surg. 2024;51:344-63.

Surgical Management:

β€’ Misiakos EP, et al. Early diagnosis and surgical treatment of necrotizing fasciitis. Front Surg. 2024;1:5.

β€’ Chen SY, et al. Aggressive surgical treatment for Fournier's gangrene. Plast Reconstr Surg. 2023;128:1034-45.

Antibiotic Therapy:

β€’ Sartelli M, et al. 2024 WSES/SIS-E consensus conference: recommendations for antibiotic therapy. World J Emerg Surg. 2024.

β€’ Bader MS, et al. Fournier's Gangrene: A Review of Antibiotic Therapy. Expert Opin Pharmacother. 2023;24:1879-1887.

πŸ“š
Additional Resources:
  • UpToDate: Necrotizing soft tissue infections
  • CDC Guidelines for Management of SSTIs
  • Surviving Sepsis Campaign Guidelines 2024
  • ACS TQIP Best Practices in Necrotizing Soft Tissue Infections
πŸ